A detailed history of Virtus Fund Advisers, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 616 shares of NTRA stock, worth $65,283. This represents 0.2% of its overall portfolio holdings.

Number of Shares
616
Previous 616 -0.0%
Holding current value
$65,283
Previous $38,000 47.37%
% of portfolio
0.2%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$37.55 - $62.64 $25,196 - $42,031
-671 Reduced 52.14%
616 $38,000
Q3 2023

Nov 08, 2023

SELL
$43.4 - $62.52 $19,139 - $27,571
-441 Reduced 25.52%
1,287 $56,000
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $81,354 - $95,316
1,728 New
1,728 $84,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.